Table 1 Patient characteristics and surgical indications by treatment group

Age (years)

59 [49–69]

64 [59–73]

BMI (kg/m²)

27 [21–50]

27 [21–32]

Parity

2 [0–4]

2 [0–6]

ASA score

2 [1–3]

1 [1–2]

Uterine weight (g)

100 [50–175]

75 [50–280]

 Atypical hyperplasia

3 (27%)

2 (33%)

 Endometrial carcinoma

8 (73%)

4 (66%)

Baseline RAND-36

581 [366–744]

670 [278–726]

QoR-40

183 [147–200]

184 [157–200]

RI-10

n.a.

n.a.